A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

About the Study

This study will validate and evaluate the performance of the IMMray PanCan-d test for pancreatic cancer diagnosis in comparison to standard of care imaging currently used in pancreatic cancer disease surveillance by the research sites’ institutions.

ENROLLMENT HAS CLOSED FOR THIS STUDY!

Type of Study

This study will enroll people who do not have pancreatic cancer, but have a higher risk of developing the disease. This is a prospective study, which will watch participants for development of pancreatic cancer over time.

What the Study Entails

• Participants will have blood samples taken and tested using the IMMray PanCan-d test.
• Participants will also undergo imaging and doctors visits consistent with the research site's pancreatic cancer screening program.
• The analysis will compare IMMray PanCan-d test results for each subject to corresponding imaging assessments performed as part of standard of care pancreatic screening surveillance.
• Any subject who shows evidence of disease while on-study will be removed from the study to receive standard of care per the hospital's guidelines.

Study Sites

United States

• Connecticut
  • New Haven, CT: Yale University
    • Contact: James Farrell by email     
• Illinois
  • Chicago, IL: University of Chicago Medical Center
    • Contact: Sonia Kupfer, MD by email
• Massachusetts
  • Boston, MA: Massachusetts General Hospital
    • Contact: Daniel Chung by email        
  • Worcester, MA: University of Massachusetts 
    • Contact: Giles Whalen by email        
• New York
  • New York, NY: New York University Hospital
    • Contact: Diane Simeone by email
  • New York, NY: Columbia University   
    • Contact: Fay Kastrinos, MD by email         
  • New York, NY: Mount Sinai Hospital
    • Contact: Aimee Lucas by email    
• Oregon
  • Portland, OR: Oregon Health & Science University
    • Contact: Brett Sheppard by email      
• Pennsylvania
  • Philadelphia, PA: University of Pennsylvania
    • Contact: Bryson Katona by email 
  • Pittsburgh, PA: University of Pittsburgh Medical Center
  • Contact: Randall Brand by email   

Canada

• Quebec
  • Montreal: The Research Institute of the McGill University Health Centre
    • Contact: George Zogopoulos by email 

Other international sites are open in the following countries:

• Spain
• Sweden
• United Kingdom     

Principal Investigator

Study Director: Rolf Ehrnström Immunovia, Inc.